SEI INVESTMENTS CO - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$13,360
-54.2%
13,633
-35.0%
0.00%
Q2 2023$29,161
-12.6%
20,9790.0%0.00%
Q1 2023$33,357
-54.4%
20,979
+78.7%
0.00%
Q4 2022$73,122
-14.0%
11,737
-7.0%
0.00%
Q3 2022$85,000
-75.4%
12,617
-4.8%
0.00%
-100.0%
Q4 2020$345,000
-92.9%
13,258
-89.8%
0.00%
-92.9%
Q3 2020$4,832,000
-32.0%
130,006
-6.2%
0.01%
-36.4%
Q2 2020$7,110,000
+113.9%
138,577
+31.4%
0.02%
+83.3%
Q1 2020$3,324,000
-30.7%
105,439
+31.1%
0.01%
-14.3%
Q4 2019$4,797,000
+479600.0%
80,452
+423331.6%
0.01%
Q4 2018$1,0000.0%190.0%0.00%
Q3 2018$1,000
-75.0%
19
-81.0%
0.00%
Q2 2018$4,000
-96.9%
100
-94.4%
0.00%
Q1 2018$128,000
+68.4%
1,775
+53.0%
0.00%
Q4 2017$76,000
+49.0%
1,160
+13.7%
0.00%
Q3 2017$51,000
-58.2%
1,020
-80.3%
0.00%
-100.0%
Q3 2015$122,000
+3966.7%
5,182
+13187.2%
0.00%
Q2 2015$3,000390.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders